Pituitary-specific knockout of the carney complex gene Prkar1a leads to pituitary tumorigenesis

Molecular Endocrinology

Volumn 22, Issue 2, 2008, Pages 380-387

  Yin, Zhirong ^a   Williams Simons, Lisa ^b   Parlow, A F ^c   Asa, Sylvia ^d   Kirschner, Lawrence S ^a,e  

^a OHIO STATE UNIVERSITY   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e 544 TMRF ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CRE RECOMBINASE; FOLLITROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR RECEPTOR; LUTEINIZING HORMONE; PROLACTIN; THYROTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CARNEY COMPLEX; CONTROLLED STUDY; GENE FUNCTION; HORMONE BLOOD LEVEL; HYPOPHYSIS CELL; HYPOPHYSIS TUMOR; KNOCKOUT GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PRKAR1A GENE; PROLACTINOMA; PROMOTER REGION; TUMOR GENE; WILD TYPE;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASE RIALPHA SUBUNIT; GROWTH HORMONE; IMMUNOHISTOCHEMISTRY; INTEGRASES; MICE; MICE, KNOCKOUT; MODELS, GENETIC; PITUITARY GLAND; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; THYROTROPIN;

ANIMALIA; MUS; RATTUS;

EID: 38749106141     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2006-0428     Document Type: Article

References (40)

1. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE 2004 The prevalence of pituitary adenomas: a systematic review. Cancer 101:613-619
2. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells Jr SA, Marx SJ 2001 Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658-5671
3. Stratakis CA, Kirschner LS, Carney JA 2001 Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:4041-4046
4. Pack SD, Kirschner LS, Pak E, Zhuang Z, Carney JA, Stratakis CA 2000 Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex). J Clin Endocrinol Metab 85:3860-3865
5. Stergiopoulos SG, Abu-Asab MS, Tsokos M, Stratakis CA 2004 Pituitary pathology in Carney complex patients. Pituitary 7:73-82
6. Soares BS, Frohman LA 2004 Isolated familial somatotropinoma. Pituitary 7:95-101
7. Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T, Ferolla P, Emy P, Colao A, De Menis E, Lecomte P, Penfornis F, Delemer B, Bertherat J, Wemeau JL, De Herder W, Archambeaud F, Stevenaert A, Calender A, Murat A, Cavagnini F, Beckers A 2006 Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 91:3316-3323
8. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:1688-1695
9. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA 2000 Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex. Nat Genet 26:89-92
10. Kirschner LS, Kusewitt DF, Matyakhina L, Towns 2nd WH, Carney JA, Westphal H, Stratakis CA 2005 A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues. Cancer Res 65:4506-4514
11. Veugelers M, Wilkes D, Burton K, McDermott DA, Song Y, Goldstein MM, La Perle K, Vaughan CJ, O'Hagan A, Bennett KR, Meyer BJ, Legius E, Karttunen M, Norio R, Kaariainen H, Lavyne M, Neau JP, Richter G, Kirali K, Farnsworth A, Stapleton K, Morelli P, Takanashi Y, Bamforth JS, Eitelberger F, Noszian I, Manfroi W, Powers J, Mochizuki Y, Imai T, Ko GT, Driscoll DA, Goldmuntz E, Edelberg JM, Collins A, Eccles D, Irvine AD, McKnight GS, Basson CT 2004 Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc Natl Acad Sci USA 101:14222-14227
12. Cushman LJ, Burrows HL, Seasholtz AF, Lewandoski M, Muzyczka N, Camper SA 2000 Cre-mediated recombination in the pituitary gland. Genesis 28:167-174
13. Matsubara S, Sato M, Mizobuchi M, Niimi M, Takahara J 1995 Differential gene expression of growth hormone (GH)-releasing hormone (GRH) and GRH receptor in various rat tissues. Endocrinology 136:4147-4150
14. McElvaine AT, Korytko AI, Kilen SM, Cuttler L, Mayo KE 2007 Pituitary-specific expression and Pit-1 regulation of the rat growth hormone-releasing hormone receptor gene. Mol Endocrinol 21:1969-1983
15. Le Y, Miller JL, Sauer B 1999 GFPcre fusion vectors with enhanced expression. Anal Biochem 270:334-336
16. Lobe CG, Koop KE, Kreppner W, Lomeli H, Gertsenstein M, Nagy A 1999 Z/AP, a double reporter for cre-mediated recombination. Dev Biol 208:281-292
17. Soriano P 1999 Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21:70-71
18. Heaney AP, Melmed S 2004 Molecular targets in pituitary tumours. Nat Rev Cancer 4:285-295
19. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L 1989 GTPase inhibiting mutations activate the α-chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340:692-696
20. Spada A, Vallar L 1992 G-protein oncogenes in acromegaly. Horm Res 38:90-93
21. Weinstein LS, Yu S, Warner DR, Liu J 2001 Endocrine manifestations of stimulatory G protein α-subunit mutations and the role of genomic imprinting. Endocr Rev 22:675-705
22. Kaltsas GA, Kola B, Borboli N, Morris DG, Gueorguiev M, Swords FM, Czirjak S, Kirschner LS, Stratakis CA, Korbonits M, Grossman AB 2002 Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours. Clin Endocrinol (Oxf) 57:443-448
23. Sandrini F, Kirschner LS, Bei T, Farmakidis C, Yasufuku-Takano J, Takano K, Prezant TR, Marx SJ, Farrell WE, Clayton RN, Groussin L, Bertherat J, Stratakis CA 2002 PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex. J Med Genet 39:e78
24. Yamasaki H, Mizusawa N, Nagahiro S, Yamada S, Sano T, Itakura M, Yoshimoto K 2003 GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24. Clin Endocrinol (Oxf) 58:464-470
25. Lania AG, Mantovani G, Ferrero S, Pellegrini C, Bondioni S, Peverelli E, Braidotti P, Locatelli M, Zavanone ML, Ferrante E, Bosari S, Beck-Peccoz P, Spada A 2004 Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein. Cancer Res 64:9193-9198
26. Mantovani G, Bondioni S, Ferrero S, Gamba B, Ferrante E, Peverelli E, Corbetta S, Locatelli M, Rampini P, Beck-Peccoz P, Spada A, Lania AG 2005 Effect of cyclic adenosine 3′,5′-monophosphate/protein kinase A pathway on markers of cell proliferation in nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 90:6721-6724
27. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA 1992 Effects of an Rb mutation in the mouse. Nature 359:295-300
28. Teixeira LT, Kiyokawa H, Peng XD, Christov KT, Frohman LA, Kineman RD 2000 p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation. Oncogene 19:1875-1884
29. Philipp-Staheli J, Kim KH, Liggitt D, Gurley KE, Longton G, Kemp CJ 2003 Distinct roles for p53, p27(Kip1), and p21(Cip1) during tumor development. Oncogene 23:905-913
30. Sotillo R, Renner O, Dubus P, Ruiz-Cabello J, Martin-Caballero J, Barbacid M, Carnero A, Malumbres M 2005 Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity. Cancer Res 65:3846-3852
31. Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L, Xiong Y 1998 CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 12:2899-2911
32. Asa SL 2001 Transgenic and knockout mouse models clarify pituitary development, function and disease. Brain Pathol 11:371-384
33. Asa SL, Ezzat S 2002 The pathogenesis of pituitary tumours. Nat Rev Cancer 2:836-849
34. Harmar AJ 2001 Family-B G-protein-coupled receptors. Genome Biol 2:REVIEWS3013
35. Asa SL, Kelly MA, Grandy DK, Low MJ 1999 Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 140:5348-5355
36. Gershengorn MC 1989 Mechanism of signal transduction by TRH. Ann NY Acad Sci 553:191-196
37. Luque RM, Amargo G, Ishii S, Lobe C, Franks R, Kiyokawa H, Kineman RD 2007 Reporter expression, induced by a growth hormone promoter-driven Cre recombinase (rGHp-Cre) transgene, questions the developmental relationship between somatotropes and lactotropes in the adult mouse pituitary gland. Endocrinology 148:1946-1953
38. Crabtree JS, Scacheri PC, Ward JM, McNally SR, Swain GP, Montagna C, Hager JH, Hanahan D, Edlund H, Magnuson MA, Garrett-Beal L, Burns AL, Ried T, Chandrasekharappa SC, Marx SJ, Spiegel AM, Collins FS 2003 Of mice and MEN1: insulinomas in a conditional mouse knockout. Mol Cell Biol 23:6075-6085
39. Bennani-Baiti IM, Asa SL, Song D, Iratni R, Liebhaber SA, Cooke NE 1998 DNase I-hypersensitive sites I and II of the human growth hormone locus control region are a major developmental activator of somatotrope gene expression. Proc Natl Acad Sci USA 95:10655-10660
40. Yin Z, Williams-Simons L, Rahwahneh L, Asa S, Kirschner LS, Development of a pituitary-specific Cre line targeted to the Pit-1 lineage. Genesis, in press